155 related articles for article (PubMed ID: 20374646)
21. A step further in understanding the biology of the folate receptor in ovarian carcinoma.
Bagnoli M; Canevari S; Figini M; Mezzanzanica D; Raspagliesi F; Tomassetti A; Miotti S
Gynecol Oncol; 2003 Jan; 88(1 Pt 2):S140-4. PubMed ID: 12586106
[No Abstract] [Full Text] [Related]
22. [Effect of reduced expression of Her2 by RNA interference on the biological characters of ovarian carcinoma cells].
Wang KF; Cui H; Feng J; Yang R; Liang XD; Chang XH; Li Y; Cheng YX; Cheng HY; Ye X
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):622-5. PubMed ID: 19087501
[TBL] [Abstract][Full Text] [Related]
23. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
[TBL] [Abstract][Full Text] [Related]
24. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
25. [Vector construction and silencing effect of Edg4 gene targeted small interfering RNA in ovarian cancer cell line].
Qiao YH; Li LX; Guo RX; Zhou W; Wang M; Zhang XY; Zhang JH; Zhao XL; Zhang MZ; Zhao GQ
Zhonghua Fu Chan Ke Za Zhi; 2007 Nov; 42(11):765-9. PubMed ID: 18307905
[TBL] [Abstract][Full Text] [Related]
26. [Preliminary study of the prohibitin protein and paclitaxel resistance in ovarian cancer].
Tang J; Cao L; Yi H; Tang C
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Dec; 37(12):1221-7. PubMed ID: 23281375
[TBL] [Abstract][Full Text] [Related]
27. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
Yu D; Wolf JK; Scanlon M; Price JE; Hung MC
Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034
[TBL] [Abstract][Full Text] [Related]
28. Decreased Src tyrosine kinase activity inhibits malignant human ovarian cancer tumor growth in a nude mouse model.
Wiener JR; Nakano K; Kruzelock RP; Bucana CD; Bast RC; Gallick GE
Clin Cancer Res; 1999 Aug; 5(8):2164-70. PubMed ID: 10473101
[TBL] [Abstract][Full Text] [Related]
29. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation.
Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL
Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793
[TBL] [Abstract][Full Text] [Related]
30. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
[TBL] [Abstract][Full Text] [Related]
31. Modulation of angiogenic phenotype alters tumorigenicity in rat ovarian epithelial cells.
Schumacher JJ; Dings RP; Cosin J; Subramanian IV; Auersperg N; Ramakrishnan S
Cancer Res; 2007 Apr; 67(8):3683-90. PubMed ID: 17440080
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of ovarian cancer growth by small interfering RNA targeting X-linked inhibitor of apoptosis gene].
Ma JJ; Chen BL; Xin XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Feb; 42(2):124-8. PubMed ID: 17442189
[TBL] [Abstract][Full Text] [Related]
33. Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer.
Lawrenson K; Grun B; Benjamin E; Jacobs IJ; Dafou D; Gayther SA
Neoplasia; 2010 Apr; 12(4):317-25. PubMed ID: 20360942
[TBL] [Abstract][Full Text] [Related]
34. [Growth inhibitory effects of THY1 gene on epithelial ovarian cancer SKOV3 cells].
Zeng LQ; Peng ZL
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jan; 27(1):84-7, 91. PubMed ID: 17259155
[TBL] [Abstract][Full Text] [Related]
35. Notch 1 signaling is active in ovarian cancer.
Rose SL; Kunnimalaiyaan M; Drenzek J; Seiler N
Gynecol Oncol; 2010 Apr; 117(1):130-3. PubMed ID: 20060575
[TBL] [Abstract][Full Text] [Related]
36. Unique roles of p160 coactivators for regulation of breast cancer cell proliferation and estrogen receptor-alpha transcriptional activity.
Karmakar S; Foster EA; Smith CL
Endocrinology; 2009 Apr; 150(4):1588-96. PubMed ID: 19095746
[TBL] [Abstract][Full Text] [Related]
37. [Expression of Jagged1 mRNA in human epithelial ovarian carcinoma tissues and effect of RNA interference of Jagged1 on growth of xenograft in nude mice].
Liu GY; Gao ZH; Li L; Song TT; Sheng XG
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):448-53. PubMed ID: 27356481
[TBL] [Abstract][Full Text] [Related]
38. IRF-1 expression is induced by cisplatin in ovarian cancer cells and limits drug effectiveness.
Pavan S; Olivero M; CorĂ D; Di Renzo MF
Eur J Cancer; 2013 Mar; 49(4):964-73. PubMed ID: 23079474
[TBL] [Abstract][Full Text] [Related]
39. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
[TBL] [Abstract][Full Text] [Related]
40. [Impact of the biological function on epithelial ovarian cancer with ITIH4 gene expression down-regulating in vitro].
Huang M; Wang Q; Zhang W; Li DR; Li L
Zhonghua Fu Chan Ke Za Zhi; 2013 Jan; 48(1):34-40. PubMed ID: 23531249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]